These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 36251624)

  • 41. Patrolling monocytes in sickle cell hemolytic conditions.
    Liu Y; Zhong H; Vinchi F; Mendelson A; Yazdanbakhsh K
    Transfus Clin Biol; 2019 May; 26(2):128-129. PubMed ID: 30898432
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood rheology and vascular function in sickle cell trait and sickle cell disease: From pathophysiological mechanisms to clinical usefulness.
    Connes P
    Clin Hemorheol Microcirc; 2024; 86(1-2):9-27. PubMed ID: 38073384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.
    Zhang D; Xu C; Manwani D; Frenette PS
    Blood; 2016 Feb; 127(7):801-9. PubMed ID: 26758915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ex Vivo Activation of Red Blood Cell Senescence by Plasma from Sickle-Cell Disease Patients: Correlation between Markers and Adhesion Consequences during Acute Disease Events.
    Chadebech P; Bodivit G; Di Liberto G; Jouard A; Vasseur C; Pirenne F; Bartolucci P
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34208829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CXCL1 and its receptor, CXCR2, mediate murine sickle cell vaso-occlusion during hemolytic transfusion reactions.
    Jang JE; Hod EA; Spitalnik SL; Frenette PS
    J Clin Invest; 2011 Apr; 121(4):1397-401. PubMed ID: 21383500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intestinal pathophysiological and microbial changes in sickle cell disease: Potential targets for therapeutic intervention.
    Dutta D; Aujla A; Knoll BM; Lim SH
    Br J Haematol; 2020 Feb; 188(4):488-493. PubMed ID: 31693163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytokine profile of sickle cell disease in Oman.
    Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
    Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease.
    Klings ES; Farber HW
    Respir Res; 2001; 2(5):280-5. PubMed ID: 11686897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease.
    Sparkenbaugh EM; Henderson MW; Miller-Awe M; Abrams C; Ilich A; Trebak F; Ramadas N; Vital S; Bohinc D; Bane KL; Chen C; Patel M; Wallisch M; Renné T; Gruber A; Cooley B; Gailani D; Kasztan M; Vercellotti GM; Belcher JD; Gavins FE; Stavrou EX; Key NS; Pawlinski R
    Blood; 2023 Apr; 141(15):1871-1883. PubMed ID: 36706361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel inflammatory role for platelets in sickle cell disease.
    Davila J; Manwani D; Vasovic L; Avanzi M; Uehlinger J; Ireland K; Mitchell WB
    Platelets; 2015; 26(8):726-9. PubMed ID: 25548984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion.
    Brittain HA; Eckman JR; Swerlick RA; Howard RJ; Wick TM
    Blood; 1993 Apr; 81(8):2137-43. PubMed ID: 8471771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cross-sectional analysis of adhesion in individuals with sickle cell disease using a standardized whole blood adhesion bioassay to VCAM-1.
    White J; Lancelot M; Gao X; McGraw BJ; Tabb C; Hines P
    Blood Cells Mol Dis; 2020 Mar; 81():102397. PubMed ID: 31864103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease.
    Beckman JD; Abdullah F; Chen C; Kirchner R; Rivera-Rodriguez D; Kiser ZM; Nguyen A; Zhang P; Nguyen J; Hebbel RP; Belcher JD; Vercellotti GM
    Front Immunol; 2020; 11():613278. PubMed ID: 33542720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resolution of sickle cell disease-associated inflammation and tissue damage with 17
    Matte A; Recchiuti A; Federti E; Koehl B; Mintz T; El Nemer W; Tharaux PL; Brousse V; Andolfo I; Lamolinara A; Weinberg O; Siciliano A; Norris PC; Riley IR; Iolascon A; Serhan CN; Brugnara C; De Franceschi L
    Blood; 2019 Jan; 133(3):252-265. PubMed ID: 30404812
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel Sickle Cell Disease Therapies: Targeting Pathways Downstream of Sickling.
    Morrone K; Mitchell WB; Manwani D
    Semin Hematol; 2018 Apr; 55(2):68-75. PubMed ID: 30616808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Red blood cell adhesion to ICAM-1 is mediated by fibrinogen and is associated with right-to-left shunts in sickle cell disease.
    Kucukal E; Man Y; Quinn E; Tewari N; An R; Ilich A; Key NS; Little JA; Gurkan UA
    Blood Adv; 2020 Aug; 4(15):3688-3698. PubMed ID: 32777069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MEK1/2 inhibitors reverse acute vascular occlusion in mouse models of sickle cell disease.
    Zhao Y; Schwartz EA; Palmer GM; Zennadi R
    FASEB J; 2016 Mar; 30(3):1171-86. PubMed ID: 26631480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Eicosanoids in sickle cell disease: potential relevance of neutrophil leukotriene B4 to disease pathophysiology.
    Setty BN; Stuart MJ
    J Lab Clin Med; 2002 Feb; 139(2):80-9. PubMed ID: 11919546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammatory potential of neutrophils detected in sickle cell disease.
    Lum AF; Wun T; Staunton D; Simon SI
    Am J Hematol; 2004 Jun; 76(2):126-33. PubMed ID: 15164377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Manifestations of Sickle Cell Disorder at Abdominal and Pelvic Imaging.
    Solomon N; Segaran N; Badawy M; Elsayes KM; Pellerito JS; Katz DS; Moshiri M; Revzin MV
    Radiographics; 2022; 42(4):1103-1122. PubMed ID: 35559660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.